amivantamab for nsclc, drug-coated balloon for isr, ibrutinib oral suspension, epcoritamab for...
Published 7 months ago • 43 plays • Length 11:53Download video MP4
Download video MP3
Similar videos
-
4:45
amivantamab and mobocertinib: side effects and treatment timing - lung cancer
-
2:28
amivantamab in patients with egfr ex20ins-mutated nsclc
-
6:07
amivantamab and mobocertinib for egfr exon-20 disease - lung cancer video library
-
16:45
amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve egfrm nsclc
-
2:03
amivantamab and lazertinib in treatment-naïve egfr-mutant nsclc
-
2:15
durvalumab (imfinzi): how it works, benefits, and side effects explained
-
5:18
expert video report on amivantamab in combination therapy for 1l treatment in egfrm, advanced nsclc
-
9:54
amivantamab combo with lazertinib favourable in post-osimertinib egfr-mutant nsclc
-
54:58
mariposa 1 y 2: rol de amivantamab en pacientes con mutación egfr en 1l y 2l de tratamiento
-
19:36
2024年asco公告 關於皮下注射或靜脈注射amivantamab(肺倍恩注射劑/rybrevant )在治療egfr突變晚期非小細胞肺癌難治性患者之療效差異 最新研究數據解析
-
5:45
amivantamab injection review, what is amivantamab vmjw injection used for, amivantamab rybrevant
-
9:02
amivantamab plus lazertinib for egfr-mutant lung cancer following progression on osimertinib
-
1:47
amivantamab and lazertinib in egfr met disease - 2022 program: targeted therapies forum - english
-
4:27
amivantamab shows robust efficacy in post-platinum therapy patients with egfr ex20ins nsclc
-
0:41
skippirr: reducing amivantamab-related irrs in egfr-m nsclc
-
6:17
asco 2021 lung recap: amivantamab and mobocertinib for egfr exon 20
-
4:17
highlights on amivantamab after progression on osimertinib in egfr-mutated nsclc: mariposa-2
-
5:07
q&a: what is the efficacy of amivantamab and lazertinib? - targeted therapies in lung cancer 2023
-
2:20
osimertinib with chemotherapy in egfr-mutated nsclc | nejm
-
0:43
the unmet need in dlbcl
-
6:14
amivantamab and lazertinib in patients with egfr nsclc - 2022 program: targeted therapies forum